BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1316464)

  • 1. Late promoter of human papillomavirus type 8 and its regulation.
    Stubenrauch F; Malejczyk J; Fuchs PG; Pfister H
    J Virol; 1992 Jun; 66(6):3485-93. PubMed ID: 1316464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive transcriptional activator of Epidermodysplasia verruciformis-associated human papillomavirus 8.
    Horn S; Pfister H; Fuchs PG
    Virology; 1993 Oct; 196(2):674-81. PubMed ID: 8396805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions.
    Haller K; Stubenrauch F; Pfister H
    Virology; 1995 Dec; 214(1):245-55. PubMed ID: 8525623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-affinity E2-binding site mediates downmodulation of E2 transactivation of the human papillomavirus type 8 late promoter.
    Stubenrauch F; Pfister H
    J Virol; 1994 Nov; 68(11):6959-66. PubMed ID: 7933077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor.
    May M; Grassmann K; Pfister H; Fuchs PG
    J Virol; 1994 Jun; 68(6):3612-9. PubMed ID: 8189499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes.
    Deau MC; Favre M; Orth G
    Virology; 1991 Oct; 184(2):492-503. PubMed ID: 1653484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual role of tumor suppressor p53 in regulation of DNA replication and oncogene E6-promoter activity of epidermodysplasia verruciformis-associated human papillomavirus type 8.
    Akgül B; Karle P; Adam M; Fuchs PG; Pfister HJ
    Virology; 2003 Apr; 308(2):279-90. PubMed ID: 12706078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors.
    Stubenrauch F; Leigh IM; Pfister H
    J Virol; 1996 Jan; 70(1):119-26. PubMed ID: 8523515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription Properties of Beta-HPV8 and HPV38 Genomes in Human Keratinocytes.
    Rehm TM; Straub E; Forchhammer S; Leiter U; Iftner T; Stubenrauch F
    J Virol; 2022 Dec; 96(23):e0149822. PubMed ID: 36394329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction.
    Rotenberg MO; Chow LT; Broker TR
    Virology; 1989 Oct; 172(2):489-97. PubMed ID: 2552659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermodysplasia verruciformis-associated human papillomavirus 8: genomic sequence and comparative analysis.
    Fuchs PG; Iftner T; Weninger J; Pfister H
    J Virol; 1986 May; 58(2):626-34. PubMed ID: 3009874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique topography of DNA-protein interactions in the non-coding region of epidermodysplasia verruciformis-associated human papillomaviruses.
    May M; Helbl V; Pfister H; Fuchs PG
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():2989-97. PubMed ID: 1662691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cDNAs of spliced HPV-11 E2 mRNA and other HPV mRNAs recovered via retrovirus-mediated gene transfer.
    Rotenberg MO; Chiang CM; Ho ML; Broker TR; Chow LT
    Virology; 1989 Oct; 172(2):468-77. PubMed ID: 2552658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomaviruses and skin cancer.
    Pfister H
    Semin Cancer Biol; 1992 Oct; 3(5):263-71. PubMed ID: 1335790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms.
    Müller-Schiffmann A; Beckmann J; Steger G
    J Virol; 2006 Sep; 80(17):8718-28. PubMed ID: 16912319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes.
    Marthaler AM; Podgorska M; Feld P; Fingerle A; Knerr-Rupp K; Grässer F; Smola H; Roemer K; Ebert E; Kim YJ; Bohle RM; Müller CSL; Reichrath J; Vogt T; Malejczyk M; Majewski S; Smola S
    PLoS Pathog; 2017 Jun; 13(6):e1006406. PubMed ID: 28640877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
    Hubert WG; Laimins LA
    J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16.
    Rohlfs M; Winkenbach S; Meyer S; Rupp T; Dürst M
    Virology; 1991 Jul; 183(1):331-42. PubMed ID: 1647072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line.
    Doorbar J; Parton A; Hartley K; Banks L; Crook T; Stanley M; Crawford L
    Virology; 1990 Sep; 178(1):254-62. PubMed ID: 2167553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
    Dong G; Broker TR; Chow LT
    J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.